Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
We are at the forefront of precision medicine, alleviating the strain on healthcare systems through our innovative automated analysis, diagnosis, and treatment solutions that cater to healthcare providers and patients globally. Congenica emerged from groundbreaking research conducted at the Wellcome Sanger Institute and the UK's National Health Service. Our offerings integrate cutting-edge technology, top-tier automation, and artificial intelligence, allowing our distinct platform to be utilized across various human diseases where genomic information plays a crucial role in revealing actionable insights. As a digital health company, we specialize in software and solutions designed for the large-scale analysis and interpretation of genomic data. Our fully automated system, enhanced with robust APIs and machine learning capabilities, aims to lighten the load on specialist staff, improve case processing efficiency, speed up decision-making, and simplify reporting. Our platform is certified, accurate, and secure, empowering clinical decisions with the utmost confidence in the resulting clinical outcomes, and we continuously strive to innovate and expand our capabilities to meet the evolving needs of the healthcare landscape.
Description
DNAnexus Apollo™ enhances the efficiency of precision drug discovery by fostering collaboration that extracts valuable insights from omics data. The process of precision drug discovery involves the aggregation and examination of vast amounts of omics and clinical information. These extensive datasets serve as valuable assets; however, many traditional and custom-built informatics tools struggle to manage their intricacies and scale. Additionally, the effectiveness of precision medicine initiatives can be hindered by fragmented data sources, inadequate collaboration tools, and the challenges posed by complex, evolving regulatory and security demands. By enabling scientists and clinicians to jointly investigate and interpret omics and clinical data within a unified framework, DNAnexus Apollo™ bolsters precision drug discovery efforts. This platform, which is powered by a resilient and scalable cloud infrastructure, facilitates the seamless and secure sharing of data, tools, and analyses among peers and collaborators, regardless of whether they are nearby or across the globe. Ultimately, Apollo not only streamlines the data-sharing process but also enhances the overall collaborative experience in the pursuit of innovative drug discoveries.
API Access
Has API
API Access
Has API
Integrations
No details available.
Integrations
No details available.
Pricing Details
No price information available.
Free Trial
Free Version
Pricing Details
No price information available.
Free Trial
Free Version
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Vendor Details
Company Name
Congenica
Founded
2014
Country
United Kingdom
Website
www.congenica.com
Vendor Details
Company Name
DNAnexus
Founded
2009
Country
United States
Website
www.dnanexus.com/product-overview/apollo